Crossmark

Combined subchondral and intra‐articular injections of bone marrow aspirate concentrate provide stable results up to 24 months

Crossref DOI link: https://doi.org/10.1007/s00167-022-07195-w

Published Online: 2022-11-03

Published Print: 2023-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kon, Elizaveta

Boffa, Angelo https://orcid.org/0000-0002-1523-6900
Andriolo, Luca

Di Martino, Alessandro

Di Matteo, Berardo

Magarelli, Nicola

Trenti, Nicoletta

Zaffagnini, Stefano

Filardo, Giuseppe
License Information

Version of Record valid from 2022-11-03

Text and Data Mining valid from 2022-11-03

Version of Record valid from 2022-11-03
More Information

Article History

Received: 27 June 2022

Accepted: 30 September 2022

First Online: 3 November 2022

Declarations

:

: EK reports consulting for Cartiheal ldt, Green Bone, Geistlich, and Bioveex, and speaking for Zimmer Biomet and Fidia Farmaceutici SPA. SZ reports non-financial support from personal fees from I + SRL, grants from Fidia Farmaceutici SPA, Cartiheal ltd, IGEA clinical biophysics, BIOMET, and Kensey Nash, outside the submitted work.The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results. The other authors declare no conflict of interest.

: Approval was obtained by the Hospital Ethics Committee of IRCCS Istituto Ortopedico Rizzoli (prot. gen. n. 0013097).

: Participation was voluntary and informed consent was obtained from each patient.